FDA
Pharma

Fresenius Medical Care hit with FDA warning letter at Utah plant

After multiple complaints, a Form 483 and a recall, a Fresenius manufacturing unit in Utah is contending with an FDA warning letter.
Fraiser Kansteiner Sep 3, 2026 3:31pm
Neurons Brain Cell Nerves Illustration

Novartis teams with Olympian Laviai Nielsen on MS campaign

Sep 3, 2026 2:19pm
video
Why real-world data is becoming a strategic asset in drug development

Why real-world data is becoming a strategic asset in drug development

Brought to you by LabCorp
FDA

FDA docs shed light on contentious nod for Replimune's Trudiqev

Sep 3, 2026 12:10pm
Pharma Doesnt Have an AI Problem It Has an Information Problem

Pharma Doesn't Have an AI Problem. It Has an Information Problem.

Brought to you by Intelligencia AI
Reorganization team change restructure

CMI forms new specialty communications business unit

Sep 3, 2026 11:35am
More News

Akeso, Summit’s ivonescimab hits OS goal in Keytruda head-to-head

Sep 3, 2026 10:29am

ESC: Amgen CMO touts Repatha 'inflection' on mortality data

Sep 3, 2026 8:30am

ARPA-H taps 5 teams to help streamline RNA therapy production

Sep 2, 2026 3:12pm

Novartis telegraphs 130 job cuts in Switzerland

Sep 2, 2026 2:15pm